C. Cannon

Current therapies for secondary prevention after myocardial infarction.

S. Smith, C. Cannon, 1999, Current opinion in cardiology.

Learning lessons from Pfizer's $800 million failure

C. Cannon, 2011, Nature Reviews Drug Discovery.